How Gyre Therapeutics GYRE sensitive is to interest rates Gyre Therapeutics Misses Estimates by 13 HITI High Tide Inc Common Shares reports 137 percent yearoveryear Q4 2025 revenue growth shares slide 243 percent today Safety SAFT Sector Impact Q1 2025 Earnings Underperform FHB First Hawaiian posts 94 revenue growth in Q1 2026 but shares dip amid investor caution